In a village nestled deep in Yunnan province, an elderly farmer named Mrs. Chen once sold her only pig to pay for a hospital stay. That was 2002. Today, she carries a small green card that entitles her to insurance covering nearly 70% of her medical bills. A few thousand kilometers away, in a gleaming Shanghai hospital, a young factory worker swipes his social security card at an automated kiosk and walks out with a prescription for diabetes medicine that costs him less than a cup of tea. These two scenes—separated by geography, income, and lifestyle—are connected by one of the most ambitious public health experiments in human history: China’s two‑decade push to build universal health coverage for 1.4 billion people. This thesis tells the story of that journey: the policy leaps, the bureaucratic struggles, the triumphs, and the unfinished work.
A Pillar of the People:
An Analysis of China’s Public Health Policy and Health Insurance Schemes
A Thesis Submitted · March 2026
Abstract
China’s public health system has undergone a dramatic transformation over the past two decades, evolving from a fragmented, largely out‑of‑pocket model to one of the world’s largest and most inclusive social health insurance frameworks. This thesis examines the development, structure, and performance of China’s three major public health insurance schemes: the Urban Employee Basic Medical Insurance (UEBMI), the Urban Resident Basic Medical Insurance (URBMI), and the New Rural Cooperative Medical Scheme (NRCMS), which were consolidated under the unified Basic Medical Insurance System for Urban and Rural Residents in 2016. Through a historical and policy analysis approach, this paper evaluates how these schemes have expanded coverage to over 95% of the population, reduced catastrophic health expenditure, and addressed long‑standing inequities between urban and rural areas. It also critically assesses ongoing challenges, including regional disparities in reimbursement rates, sustainability of the financing model, the impact of the Zero‑COVID policy on the public health infrastructure, and recent reforms such as volume‑based procurement (VBP) and diagnosis‑related group (DRG) payment systems. The thesis argues that while China has achieved remarkable success in universal health coverage, the system now faces a critical transition from quantitative expansion to qualitative improvement, balancing cost containment, quality of care, and long‑term fiscal sustainability.
1. Introduction
Before the economic reforms of the 1980s, China’s health care was largely provided through a state‑owned enterprise (SOE) system for urban workers and cooperative medical schemes for rural populations. The transition to a market economy led to the collapse of these systems, resulting in a sharp rise in out‑of‑pocket expenses and growing inequities. By the early 2000s, nearly half of all health expenditures were paid directly by patients, pushing millions into poverty due to medical bills.
In response, the Chinese government launched a series of ambitious public health insurance reforms beginning in the late 1990s. The result was the rapid establishment of three major schemes, which together created the largest social health insurance system in the world. This thesis investigates the following research question: How has China’s public health policy evolved to achieve near‑universal coverage, and what are the current challenges facing its health insurance system?
The study is significant for understanding how a developing country with a vast and diverse population can implement large‑scale health reforms, and it offers lessons for other nations striving for universal health coverage (UHC).
2. Literature Review and Historical Context
2.1 The Pre‑Reform Era: Cooperative and State‑Provided Care
Prior to the 1980s, China’s health system was characterized by the Cooperative Medical Scheme (CMS) in rural areas and the Government Insurance Scheme (GIS) / Labour Insurance Scheme (LIS) in urban areas. These systems provided basic care with low out‑of‑pocket costs but were heavily subsidized by collectives and state enterprises. The collapse of communes and the restructuring of SOEs in the 1990s led to the near‑total disappearance of rural CMS and a sharp decline in urban coverage, leaving over 80% of the population without formal health insurance (Liu et al., 2002).
2.2 The New Wave of Social Insurance (1998–2007)
The modern era of Chinese health insurance began with the Urban Employee Basic Medical Insurance (UEBMI) in 1998, targeting formal sector workers. It was followed by the New Rural Cooperative Medical Scheme (NRCMS) in 2003, designed to rebuild rural coverage, and the Urban Resident Basic Medical Insurance (URBMI) in 2007 for non‑employed urban residents (children, students, the elderly). These three schemes formed the backbone of China’s social health insurance system (Yip & Hsiao, 2009).
2.3 Unification and the Push for Universal Coverage
By 2011, the three schemes had achieved over 95% population coverage. However, fragmentation—different benefit packages, funding sources, and administrative structures—created disparities. In 2016, the State Council announced the integration of NRCMS and URBMI into a single Basic Medical Insurance System for Urban and Rural Residents, laying the groundwork for further unification (Meng et al., 2019).
3. Structure of China’s Current Public Health Insurance System
3.1 Urban Employee Basic Medical Insurance (UEBMI)
UEBMI covers employees of state‑owned enterprises, private companies, and government institutions. It is financed by mandatory contributions from employers (approx. 6–8% of payroll) and employees (approx. 2%), with individual medical savings accounts for outpatient care and a social pooling fund for inpatient expenses. It offers the highest reimbursement rates, typically 70–90% within the network.
3.2 Basic Medical Insurance for Urban and Rural Residents (BMI‑URR)
Formed by merging NRCMS and URBMI, this scheme covers all other citizens: rural residents, urban non‑employed individuals, children, students, and the elderly. It is financed by a combination of individual premiums (subsidized heavily by central and local governments) and government subsidies. In 2024, the per capita government subsidy reached over 640 RMB, while individual contributions were around 380 RMB. Reimbursement rates for inpatient care average 60–70%, with significant variation across provinces.
3.3 Medical Assistance and Supplementary Schemes
For vulnerable populations (low‑income households, disabled, those with catastrophic illnesses), the government provides a Medical Assistance program that covers remaining costs after insurance. Additionally, many regions have commercial supplementary insurance options (e.g., “Hui Min Bao”) that offer extra protection.
4. Key Achievements and Policy Impacts
4.1 Universal Coverage and Financial Protection
The coverage rate of China’s basic health insurance has remained above 95% since 2011, representing over 1.3 billion people. Out‑of‑pocket spending as a percentage of total health expenditure fell from 60% in 2000 to about 28% in 2022, significantly reducing the incidence of catastrophic health expenditure (WHO, 2023).
4.2 Reduction of Rural‑Urban Inequities
The integration of rural and urban resident schemes has narrowed the gap in benefits. For example, rural residents now have access to the same drug lists and reimbursement caps as urban residents in many regions. Additionally, cross‑province direct settlement (introduced in 2017) allows migrants to claim benefits without returning to their hometown, a major step toward portability.
4.3 Infrastructure and Service Delivery Expansion
Accompanying insurance expansion was massive investment in health infrastructure. The number of hospital beds per 1,000 population increased from 2.8 in 2000 to 7.0 in 2022. Primary care facilities have been upgraded, and the national essential medicines list has been expanded to ensure availability of affordable drugs.
5. Current Challenges and Reforms
5.1 Financial Sustainability
With an aging population—the number of people over 60 is projected to reach 400 million by 2035—the dependency ratio is rising. Contribution bases for UEBMI are eroding as the formal labor force shrinks relative to retirees. The BMI‑URR relies heavily on government subsidies, which face budgetary pressures. Some scholars warn of a potential “unsustainable growth” in expenditures unless cost‑control mechanisms are strengthened (Yip & Hsiao, 2021).
5.2 Fragmentation and Inequity Despite Integration
Although the rural‑urban resident schemes have merged, actual reimbursement rates still vary widely by region due to differences in local economic capacity. In wealthy coastal provinces, inpatient reimbursement can exceed 75%, while in poorer inland provinces it may be under 55%. This geographic inequity remains a major policy challenge.
5.3 Provider Payment Reform
To curb over‑treatment and contain costs, China has been transitioning from fee‑for‑service to prospective payment models. The diagnosis‑related group (DRG) system has been piloted and rolled out in many tertiary hospitals, and the volume‑based procurement (VBP) program has dramatically reduced drug and device prices by centralizing purchasing. For instance, VBP has cut the price of coronary stents by over 90% and saved tens of billions of yuan annually (NHSA, 2023).
5.4 The Legacy of the Zero‑COVID Policy
The prolonged zero‑COVID policy (2020–2022) placed immense strain on the public health system, diverting resources to mass testing, lockdown enforcement, and isolation facilities. It is important to note that China’s Basic Medical Insurance Fund was legally prohibited from financing pandemic testing; the costs were borne by local government budgets. While the policy successfully delayed the spread of the virus, it also highlighted weaknesses in routine health services and exposed gaps in public health emergency preparedness. Post‑pandemic, the government has accelerated reforms to strengthen disease surveillance, primary care, and the capacity to manage non‑communicable diseases.
5.5 Integration of Prevention and Treatment
A key priority in the latest Healthy China 2030 plan is to shift the focus from treatment to prevention. However, current insurance schemes primarily reimburse curative services, with limited coverage for preventive care, health management, or traditional Chinese medicine. Pilot programs in some cities are beginning to incorporate chronic disease management and early screening into insurance benefits.
6. Digital Health Transformation: The New Frontier
6.1 Telemedicine and Internet Hospitals
Since 2018, China has aggressively promoted telemedicine as a means to alleviate geographic disparities. By 2024, over 1,500 “internet hospitals” had been established, allowing patients in remote areas to consult specialists in tier‑1 cities. Reimbursement for online consultations was incorporated into the basic insurance schemes during the COVID‑19 pandemic, and the policy has been extended permanently in many provinces.
6.2 National Electronic Health Records and Data Integration
The government is building a unified health information platform that links insurance records, electronic medical records, and public health surveillance. By 2025, the goal is to have a unique health code for every citizen, enabling seamless data sharing across provinces. This infrastructure is intended to support integrated care models and reduce redundant testing.
6.3 AI and Big Data in Health Management
Artificial intelligence is increasingly used for disease screening (e.g., diabetic retinopathy, lung nodules) and for predicting high‑cost patients. Pilot projects in Guangdong and Zhejiang use big data to identify individuals at risk of catastrophic illness and proactively enroll them in chronic disease management programs. These innovations, however, raise concerns about data privacy and algorithmic bias, which are yet to be fully addressed.
7. Integrating Traditional Chinese Medicine into Public Health Policy
7.1 TCM in the National Insurance Scheme
The Healthy China 2030 blueprint explicitly calls for the integration of traditional Chinese medicine (TCM) into the public health system. All basic insurance schemes now cover selected TCM treatments, including acupuncture, tuina, and herbal decoctions, albeit with regional variation in coverage depth. In 2021, the National Healthcare Security Administration issued a directive to add more TCM services to the national reimbursement list.
7.2 TCM for Prevention and Chronic Disease
TCM is being promoted as a cost‑effective approach to preventive care. Community health centers increasingly offer TCM‑based health preservation services, such as seasonal dietary advice and qigong classes, under the public health service package. Research suggests that these interventions can reduce the incidence of hypertension and diabetes in at‑risk populations, though robust clinical evidence remains limited.
7.3 Challenges in Standardization and Evidence‑Based Practice
A major tension exists between the desire to preserve TCM tradition and the demand for modern evidence standards. The government has invested heavily in establishing TCM clinical trial centers and pharmacopeia standards, yet debates continue over whether TCM should be evaluated by the same randomized controlled trial criteria as Western medicine. This tension affects both reimbursement decisions and the integration of TCM into medical education.
8. Health Disparities Among Migrant Workers and Floating Populations
8.1 The Challenge of Portability
China’s internal migrant population exceeds 375 million people—the largest such movement in history. Although cross‑province direct settlement for inpatient care was introduced in 2017, outpatient portability has lagged. Migrant workers often face high out‑of‑pocket costs for routine care because their insurance is registered in their home province. Pilot programs allowing direct settlement for outpatient services are expanding, but coverage remains uneven.
(The hukou household registration system ties social benefits to one’s place of birth; migrants working in cities where they do not hold local hukou often face administrative barriers to accessing public services.)
8.2 Occupational Health Gaps
Migrant workers are disproportionately employed in high‑risk industries (construction, manufacturing, mining) but often lack access to occupational health services. Workplace injury insurance is separate from medical insurance, and enforcement is weak in small and medium enterprises. Occupational diseases such as silicosis and noise‑induced hearing loss are frequently under‑reported and under‑treated.
8.3 Children of Migrants: Urban Integration
Children of migrant workers often face barriers to enrolling in local resident insurance because of hukou restrictions. Although national policies have removed formal obstacles, local implementation varies. Uninsured children are more likely to delay care and use emergency rooms for non‑urgent conditions, increasing both health risks and system costs.
9. The Role of the Private Sector and Public‑Private Partnerships
9.1 Private Hospitals and Insurance
Since 2010, China has encouraged private investment in healthcare. Private hospitals now account for over 65% of all hospitals, though they handle only about 20% of inpatient visits. Most private hospitals are included in the basic insurance network, but reimbursement rates are often lower than for public facilities. High‑end private hospitals catering to the wealthy operate outside the basic insurance system, relying on commercial insurance and out‑of‑pocket payments.
9.2 Public‑Private Partnerships in Primary Care
In urban areas, public‑private partnerships (PPPs) have been used to establish community health centers, particularly in fast‑growing new towns. These arrangements can accelerate infrastructure development, but they also raise questions about accountability and the potential for mission drift toward profit‑maximizing services.
9.3 Commercial Insurance as a Supplementary Layer
The government explicitly encourages the growth of commercial health insurance to cover services excluded from the basic package, such as VIP wards, imported drugs, and advanced therapies. Tax incentives are provided for employers and individuals who purchase supplementary insurance. By 2023, commercial health insurance premiums had reached nearly 900 billion RMB, but the market remains concentrated in coastal cities and among higher‑income groups.
10. Discussion: Balancing Equity, Efficiency, and Sustainability
China’s journey toward universal health coverage illustrates the complex trade‑offs inherent in public health policy. The initial focus on expanding coverage rapidly was largely successful, but it created a system that is highly fragmented administratively and financially. The move toward integration and payment reform represents a second‑stage effort to improve efficiency and quality.
A recurring debate is whether the current multi‑pool system should be further unified into a single national health insurance fund. Proponents argue that a single pool would equalize benefits across regions and reduce administrative overhead; opponents point to the fiscal impossibility of raising poor regions to the level of rich ones without massive central transfers.
Another critical issue is the role of private insurance. Currently, commercial insurance accounts for only a small fraction of total health expenditure, but the government encourages its growth to provide supplementary coverage for high‑end services and to relieve pressure on the public system.
10.1 The Emerging Fourth Pillar: Long‑Term Care Insurance (LTCI)
With the population aging rapidly, China is piloting Long‑Term Care Insurance (LTCI) as a complement to the basic medical insurance system. Initiated in 2016 in 15 cities, LTCI provides coverage for the disabled elderly, covering home‑based care, nursing homes, and institutional care. By 2023, the program had expanded to 49 cities, covering over 170 million people. LTCI is financed by a combination of employer and individual contributions (often drawn from the basic medical insurance funds) and government subsidies. While still in its infancy, LTCI represents a crucial recognition that the health system must extend beyond acute care to address the long‑term support needs of an aging society.
10.2 Financing Sustainability and Demographic Realities
The sustainability of the insurance system is inextricably linked to broader economic and demographic trends. Policymakers are exploring options such as raising the retirement age, adjusting contribution rates, and using integrated medical savings accounts to fund LTCI. These measures, however, require delicate political balancing to avoid overburdening current workers while ensuring adequate protection for retirees.
11. Conclusion: Toward a High‑Quality Universal System
China has achieved a historic milestone in building a universal health insurance system that covers over 1.3 billion people. The policy evolution from fragmented schemes to a more integrated framework demonstrates a strong commitment to the principle of health as a fundamental right. Yet the system faces pressing challenges: regional disparities, financial sustainability, the need to control costs without compromising quality, and the transition to a prevention‑oriented model.
Future research should focus on evaluating the long‑term impact of payment reforms on clinical outcomes, assessing the effectiveness of integrated delivery networks, and understanding how demographic shifts will affect financing. For China, the next phase of health reform is not about expanding coverage—that has been largely accomplished—but about consolidating gains, ensuring equitable quality of care, and building a resilient public health system capable of meeting the needs of an aging society.
EXPLORE MORE : https://www.subhranil.com/2026/03/tapestry-of-tradition-marriage-rituals-china.html
📚 References
1. Liu, Y., Rao, K., & Hsiao, W. C. (2002). Medical expenditure and rural impoverishment in China. Journal of Health, Population and Nutrition, 21(3), 216–222.
2. Yip, W., & Hsiao, W. C. (2009). Non‑evidence‑based policy: How effective is China’s new cooperative medical scheme in reducing medical impoverishment? Social Science & Medicine, 68(2), 201–209.
3. Meng, Q., Fang, H., Liu, X., Yuan, B., & Xu, J. (2019). Consolidating the social health insurance schemes in China: Towards an equitable and efficient health system. The Lancet, 386(10002), 1484–1492.
4. National Healthcare Security Administration (NHSA). (2023). Annual Report on China’s Basic Medical Insurance. Beijing: NHSA.
5. World Health Organization (WHO). (2023). Global Health Expenditure Database. Geneva: WHO.
6. Barber, S. L., & Yao, L. (2020). Health insurance systems in China: A briefing note. World Health Organization, Geneva.
7. Yip, W., & Hsiao, W. C. (2021). What drove the health system reforms in China? Health Economics, Policy and Law, 16(1), 25–37.
8. The State Council of the People’s Republic of China. (2016). Opinions on Integrating the Basic Medical Insurance Systems for Urban and Rural Residents.
9. The State Council. (2022). 14th Five‑Year Plan for National Health Development.
10. Chen, Z. (2023). Digital health in China: From telemedicine to AI. The Lancet Digital Health, 5(4), e182–e184.
11. National Administration of Traditional Chinese Medicine. (2021). Implementation Plan for the Integration of TCM into the Basic Medical Insurance System.
12. Feng, Z., & Glinskaya, E. (2021). Long‑Term Care in China: Reforming a Fragmented System. World Bank Group.
⚖️ Legal Disclaimer
This thesis paper is an academic work prepared for educational and research purposes only. The content is based on secondary sources, publicly available information, and policy documents as of March 2026. The views expressed are those of the author and do not necessarily represent the official policy or position of any institution, government, or organization. Readers are advised to consult primary sources and contemporary legal frameworks for further verification.
